BIOINTERVENE
BioIntervene is a preclinical-stage biopharmaceutical company committed to the discovery and development of effective and non-addictive medicines for chronic pain and other chronic inflammatory and neurodegenerative disorders. The Company was founded in 2014 based on insights from research at Saint Louis University and the National Institutes of Health (NIH). BioIntervene’s founding team has pioneered the understanding of adenosine A3 receptor biology, with a focus on developing first-in-class, selective adenosine A3 receptor agonists.
BIOINTERVENE
Social Links:
Industry:
Biotechnology Health Care Medical Pharmaceutical
Founded:
2014-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.biointervene.com
Total Employee:
1+
Status:
Active
Contact:
(619) 817-9478
Email Addresses:
[email protected]
Total Funding:
38.77 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default LetsEncrypt WordPress Apache Sitelinks Search Box Organization Schema Google Apps For Business
Similar Organizations
AB2 Bio
AB2 Bio is a drug discovery and development company.
Acellera
Acellera is a company devoted to speed up drug discovery and development.
BioMed Valley Discoveries, Inc.
Scientific Discovery Development
Bohai New Enzyme
Bohai New Enzyme is a special enzyme research and development manufacturer.
Bridge Medicines
Bridge Medicines is a drug discovery company
Capella BioScience
Capella Bioscience engages in the discovery and development of monoclonal antibodies.
ChoiPharm
ChoiPharm is a high-tech enterprise specializing in drug research and development.
Clyde Biosciences
Improving success in drug discovery
CV Sciences
CV Sciences are integrating science and nature, improving health and well-being.
Delta 4
Delta 4 is a biotech startup driving the forefront of digital drug discovery and development.
Drug Delivery Experts
Drug Delivery Experts is a boutique drug product development firm.
DrugPredict
DrugPredict.com is an online drug repositioning, discovery and development tool
Editas Medicine
Editas Medicine is engaged in discovering and developing a novel class of genome editing therapeutics.
Enspire Bio
Enspire Bio is a drug discovery company
Exo Therapeutics
Exo Therapeutics is a small molecule drug discovery and development company.
Frontier Pharma
Frontier Pharma is a medical research and development firm.
GB Sciences
GB Sciences (GBS) (OTC:GBLX) is a research and biotechnical development company.
Ibex Biosciences
Ibex Biosciences engages in a diverse approach to research and development.
Micot
Micot is a peptide and protein drug developer.
MitraSpan
MitraSpan is a privately held medical device development company.
MKBC
MKBC specializes in the integration of drug research and development.
Moderna Therapeutics
Moderna Therapeutics is a biotechnology company that specializes in drug discovery and drug development based on messenger RNA.
Novocare
Novocare is a medical equipment research and development company
NuChem Sciences
NuChem Sciences is a drug discovery in chemistry contract research organization (CRO) located in Montréal and Lévis.
Orbiepharm
Orbiepharm is a pet medicine and western medicine research and development company.
Regenex Corporation
Regenex Corporation engages in the reproductive health drug development business.
Shenogen Pharma Group
Shenogen Pharma Group is a drug discovery and development company.
Silicon Therapeutics
Silicon Therapeutics is a fully integrated drug design, research, and development company.
Skuny Bioscience
Skuny Bioscience is a health nutrition research and development company.
Thelial Technologies
Thelial Technologies engages in targeted carcinoma drug discovery and development.
Transposagen Biopharmaceuticals
Transposagen Biopharmaceuticals provides animal models of human diseases for drug discovery and development.
Tylenol
Tylenol is a brand of drug used to treat fever and mild to moderate pain.
VaxForm
VaxForm offers vaccine product consultation and contract development services.
Virogin Biotech
Virogin Biotech is an antineoplastic drug developer.
Zion Pharma
Zion Pharma is a drug discovery platform.
ZSPepLib
ZSPepLib is a polypeptide drug developer.
Current Advisors List
Current Employees Featured
Founder
Investors List
MPM Capital
MPM Capital investment in Series A - BioIntervene
Key Employee Changes
| Date | New article |
|---|---|
| 2020-01-06 | BioIntervene Taps Charles Cohen as Its Chief Scientific Officer |
Official Site Inspections
http://www.biointervene.com
- Host name: kpmurphyweb.com
- IP address: 208.113.216.164
- Location: Brea United States
- Latitude: 33.9339
- Longitude: -117.8854
- Metro Code: 803
- Timezone: America/Los_Angeles
- Postal: 92821
More informations about "BioIntervene"
BioIntervene - Crunchbase Company Profile & Funding
BioIntervene is engages in drug discovery and development. BioIntervene is a preclinical-stage biopharmaceutical company committed to the discovery and development of effective and non-addictive medicines for chronic pain and …See details»
BioIntervene - VentureRadar
" BioIntervene, Inc. is a preclinical-stage biopharmaceutical company committed to the discovery and development of effective and non-addictive medicines for chronic pain and other chronic …See details»
BioIntervene - Org Chart, Teams, Culture & Jobs | The Org
View BioIntervene's up-to-date org chart, open roles, and culture details. Find executives, board members, teams, related companies, and more.See details»
Biointervene Company Profile 2024: Valuation, Funding
Biointervene General Information Description. Developer of first-in-class and selective A3 adenosine receptor analgesics intended to treat neuropathic pain. The company focuses on …See details»
BioIntervene Inc. Company Profile | San Diego, CA | Competitors ...
Find company research, competitor information, contact details & financial data for BioIntervene Inc. of San Diego, CA. Get the latest business insights from Dun & Bradstreet.See details»
The views, opinions and/or findings contained in this report are …
CONTRACTING ORGANIZATION: BioIntervene Inc. REPORT DATE: October 2020 . Type of Report: Annual . PREPARED FOR: U.S. Army Medical Research and Development …See details»
BioIntervene - Funding, Financials, Valuation & Investors
How much funding has this organization raised over time? Show . Announced Date . Transaction Name . Number of Investors . Money Raised . Lead Investors . Jun 23, 2021: ... Series A - …See details»
BioIntervene - Crunchbase
BioIntervene is engages in drug discovery and development.See details»
BioIntervene | Qualifyze
BioIntervene, Inc. is a preclinical-phase pharmaceutical company dedicated to discovering and creating effective and non-habit-forming medications for long-lasting discomfort and other long …See details»
SLU Startup Raises $30 Million in Bid to Better Manage Pain
Jan 28, 2020 In one of the biggest investments in research commercialization in Saint Louis University’s history, BioIntervene, a biopharmaceutical company founded in 2014 by Saint …See details»
BioIntervene | VentureRadar
BioIntervene, Inc. is a preclinical-stage biopharmaceutical company committed to the discovery and development of effective and non-addictive medicines for chronic pain and other chronic …See details»
BioIntervene - Products, Competitors, Financials, Employees ...
BioIntervene takes on adenosine in pain, raises $30M. Jan 14, 2020. BIOCENTURY BioIntervene founder pinpoints an adenosine receptor that may be able to safely treat neuropathic pain By …See details»
BioIntervene Inc. to Present Clinical Results of New Class of High ...
BioIntervene’s A 3 AR has the ability to reverse neuropathic pain’s resistance to opiate analgesia, ... Since its inception in 2001, Dr. Singla has served in several roles within the organization …See details»
Series A - BioIntervene - 2020-01-06 - Crunchbase
Jan 6, 2020 Organization Name . BioIntervene . Announced Date Jan 6, 2020; Funding Type Series A; Funding Stage Early Stage Venture; Money Raised . obfuscated. obfuscated. Lead …See details»
BioIntervene Announces $30 Million Series A Financing
Jan 6, 2020 BioIntervene was founded in 2014 by Dr. Daniela Salvemini, Professor and Interim Chair of the Department of Pharmacology and Physiology at Saint Louis University, who …See details»
BioIntervene Raises $30M to Move Nerve Pain Drug Into the Clinic
In the past seven years BioIntervene has been working to develop “ultra-selective” compounds to target an adenosine receptor associated with pain relief. Now the San Diego-based biotech …See details»
BioIntervene takes on adenosine in pain, raises $30M
Jan 7, 2020 With IP from St. Louis University and NIH, BioIntervene raised a $30 million series A round from MPM Capital to bring what could be a first-in-class pain therapy into the clinic.. The …See details»
BioIntervene - Contacts, Employees, Board Members, Advisors
Organization. BioIntervene . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. Highlights. Employee Profiles 2. Number of Board …See details»
Biointervene discovers new adenosine A3 receptor agonists
Apr 17, 2024 Biointervene Inc. has described adenosine analogues acting as adenosine A3 receptor (ADORA3) agonists reported to be useful for the treatment of mild cognitive …See details»
Gary Bennett - Founder and Chief Executive Officer @ BioIntervene ...
Gary Bennett is the Founder and CEO of BioIntervene. Search Crunchbase. Start Free Trial . Chrome Extension. Solutions. Products. Resources. ... Number of Founded Organizations 1. …See details»